10X Genomics (TXG) PT Lowered to $50 at Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts TXG Hot Sheet
Price: $76.41 -5.26%
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 46
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 46
Join SI Premium – FREE
Cowen analyst Dan Brennan lowered the price target on 10X Genomics (NASDAQ: TXG) to $50.00 (from $90.00) while maintaining a Outperform rating.
You May Also Be Interested In
- 10X Genomics (TXG) PT Raised to $100 at Canaccord
- Artisan Partners Asset Management (APAM) PT Lowered at TD Cowen After 'Another Attrition-Driven Miss'
- Schrodinger (SDGR) PT Raised to $30 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
